Adipose Tissue from Lean and Obese Mice Induces a Mesenchymal to Epithelial Transition-Like Effect in Triple Negative Breast Cancers Cells Grown in 3-Dimensional Culture

Adipose Tissue from Lean and Obese Mice Induces a Mesenchymal to Epithelial Transition-Like Effect in Triple Negative Breast Cancers Cells Grown in 3-Dimensional Culture

Breast cancer is the second leading cause of cancer-related mortality among women globally with obesity being one risk factor. Obese breast cancer patients have at least a 30% increased risk of death from breast cancer compared to non-obese breast cancer patients because they present with larger tum...

Full description

Bibliographic Details
Main Authors:	Emmanuel C. Asante, Nikitha K. Pallegar, Alica J. Hoffmann, Alicia M. Viloria-Petit, Sherri L. Christian
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	International Journal of Molecular Sciences
Subjects:	MET metastasis breast cancer triple negative breast cancer obesity adipose tissue
Online Access:	https://www.mdpi.com/1422-0067/21/17/6439

Similar Items

Identification of lysyl oxidase as an adipocyte-secreted mediator that promotes a partial mesenchymal-to-epithelial transition in MDA-MB-231 cells
by: Cassidy M. Van Stiphout, et al.
Published: (2024-01-01)

Altered Adipokine Expression in Tumor Microenvironment Promotes Development of Triple Negative Breast Cancer
by: Efthymia Papakonstantinou, et al.
Published: (2022-08-01)

Associations of Computed Tomography Image-Assessed Adiposity and Skeletal Muscles with Triple-Negative Breast Cancer
by: Livingstone Aduse-Poku, et al.
Published: (2022-04-01)

Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines
by: Aleksandra Simiczyjew, et al.
Published: (2018-09-01)

Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells
by: Getinet M. Adinew, et al.
Published: (2022-05-01)

Does triple negative breast cancer subtype carry poorer prognosis as compared to non-triple negative breast cancer lesion - A study from a tertiary hospital
by: Srijan Basu, et al.
Published: (2023-11-01)

Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities
by: Sylvia Annabel Dass, et al.
Published: (2021-01-01)

Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells
by: Kajal Rajput, et al.
Published: (2022-09-01)

Triple-negative breast cancer arising in a fibroadenoma in BRCA 1 mutated patient
by: Nicole Brunetti, et al.
Published: (2023-01-01)

Systemic Therapy for Metastatic Triple Negative Breast Cancer: Current Treatments and Future Directions
by: Laura Morrison, et al.
Published: (2023-07-01)

The Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy and the Epithelial–Mesenchymal Transition
by: Stefano Zapperi, et al.
Published: (2023-03-01)

Presentation and treatment of aggressive, Triple‐Negative carcinosarcoma of the breast
by: Niels Vizgan, et al.
Published: (2022-07-01)

A case report and literature review on a rare subtype of triple-negative breast cancer in children
by: Lexiang Shi, et al.
Published: (2023-09-01)

TRIPLE TEST AND ALGORITHM IN DIAGNOSIS OF BREAST TUMORS
by: Türkan Rezanko
Published: (2008-07-01)

Modern Immunotherapy in the Treatment of Triple-Negative Breast Cancer
by: Jakub Wesolowski, et al.
Published: (2022-08-01)

Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling
by: Xiwei Ji, et al.
Published: (2023-01-01)

Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach
by: Hana Kim, et al.
Published: (2021-11-01)

Androgen receptors: unclear ubiquitious mechanism or the missing key in the triple–negative breast cancer?
by: Ana Tečić-Vuger, et al.
Published: (2020-01-01)

Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer
by: So-Woon Kim, et al.
Published: (2021-08-01)

The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer
by: Getinet M. Adinew, et al.
Published: (2022-10-01)

Update on Classic and Novel Approaches in Metastatic Triple-Negative Breast Cancer Treatment: A Comprehensive Review
by: Salvatore Greco, et al.
Published: (2023-06-01)

Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment
by: Getinet M. Adinew, et al.
Published: (2021-12-01)

Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type
by: Md Abdus Subhan, et al.
Published: (2023-04-01)

Management of early-stage triple-negative breast cancer: recommendations of a panel of experts from the Brazilian Society of Mastology
by: Ruffo Freitas-Junior, et al.
Published: (2022-11-01)

EGCG inhibits the inflammation and senescence inducing properties of MDA-MB-231 triple-negative breast cancer (TNBC) cells-derived extracellular vesicles in human adipose-derived mesenchymal stem cells
by: Narjara Gonzalez Suarez, et al.
Published: (2023-10-01)

Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research
by: Mariona Pont, et al.
Published: (2023-09-01)

The Triple Adipose-Derived Stem Cell Exosome Technology as a Potential Tool for Treating Triple-Negative Breast Cancer
by: Andrea Pagani, et al.
Published: (2024-04-01)

Local Treatment of Triple-Negative Breast Cancer: Is Mastectomy Superior to Breast-Conserving Surgery?
by: Alba Di Leone, et al.
Published: (2023-05-01)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
by: Marisa Leeha, et al.
Published: (2023-05-01)

Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway
by: Jie Li, et al.
Published: (2018-07-01)

Platinum chemotherapy for early triple-negative breast cancer
by: Sofia RE. Mason, et al.
Published: (2024-06-01)

The role of IMP3 immunohistochemistry expression in triple-negative breast cancer as a prognostic factor
by: K Kamala, et al.
Published: (2024-01-01)

The Importance of Breast Adipose Tissue in Breast Cancer
by: Charu Kothari, et al.
Published: (2020-08-01)

The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer
by: Amarilis de Lima Campos, et al.
Published: (2023-03-01)

Prognostic analysis of breast-conserving surgery or mastectomy in patients with stage Ⅰ-Ⅲ triple-negative breast cancer
by: ZHU Qiaoli, MIAO Yiming, CHEN Xiaosong
Published: (2023-07-01)

Can MRI Biomarkers Predict Triple-Negative Breast Cancer?
by: Giuliana Moffa, et al.
Published: (2020-12-01)

Elevated mRNA expression levels of inflammation-related genes in triple-negative breast cancer: A pilot study from North East India
by: Rizwana Sultana, et al.
Published: (2021-01-01)

Establishment of triple-negative breast cancer cells based on BMI: A novel model in the correlation between obesity and breast cancer
by: Daniela Shveid Gerson, et al.
Published: (2022-12-01)

Response to cisplatin in a metastatic triple-negative breast cancer patient
by: Budhi Singh Yadav, et al.
Published: (2021-01-01)

Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells
by: Patricia Gaule, et al.
Published: (2019-04-01)